1. Home
  2. SILO vs MEGL Comparison

SILO vs MEGL Comparison

Compare SILO & MEGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SILO
  • MEGL
  • Stock Information
  • Founded
  • SILO 2010
  • MEGL 2016
  • Country
  • SILO United States
  • MEGL Hong Kong
  • Employees
  • SILO N/A
  • MEGL N/A
  • Industry
  • SILO Apparel
  • MEGL Finance: Consumer Services
  • Sector
  • SILO Consumer Discretionary
  • MEGL Finance
  • Exchange
  • SILO Nasdaq
  • MEGL Nasdaq
  • Market Cap
  • SILO 8.8M
  • MEGL 9.0M
  • IPO Year
  • SILO N/A
  • MEGL 2022
  • Fundamental
  • Price
  • SILO $1.66
  • MEGL $0.52
  • Analyst Decision
  • SILO
  • MEGL
  • Analyst Count
  • SILO 0
  • MEGL 0
  • Target Price
  • SILO N/A
  • MEGL N/A
  • AVG Volume (30 Days)
  • SILO 9.1M
  • MEGL 402.2K
  • Earning Date
  • SILO 02-14-2025
  • MEGL 10-30-2024
  • Dividend Yield
  • SILO N/A
  • MEGL N/A
  • EPS Growth
  • SILO N/A
  • MEGL N/A
  • EPS
  • SILO N/A
  • MEGL N/A
  • Revenue
  • SILO $72,102.00
  • MEGL $1,976,138.00
  • Revenue This Year
  • SILO $1.86
  • MEGL N/A
  • Revenue Next Year
  • SILO N/A
  • MEGL N/A
  • P/E Ratio
  • SILO N/A
  • MEGL N/A
  • Revenue Growth
  • SILO N/A
  • MEGL 67.75
  • 52 Week Low
  • SILO $0.77
  • MEGL $0.41
  • 52 Week High
  • SILO $4.50
  • MEGL $1.38
  • Technical
  • Relative Strength Index (RSI)
  • SILO 52.57
  • MEGL 42.45
  • Support Level
  • SILO $1.56
  • MEGL $0.49
  • Resistance Level
  • SILO $1.89
  • MEGL $0.54
  • Average True Range (ATR)
  • SILO 0.19
  • MEGL 0.05
  • MACD
  • SILO -0.05
  • MEGL -0.01
  • Stochastic Oscillator
  • SILO 27.12
  • MEGL 24.26

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

About MEGL Magic Empire Global Limited

Magic Empire Global Ltd is a financial services provider in Hong Kong which principally engage in the provision of corporate finance advisory services and underwriting services. The companys offerings mainly comprise of IPO sponsorship services, Financial advisory and independent financial advisory services, Compliance advisory services, Underwriting services, Corporate service.

Share on Social Networks: